SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 43 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$76,000
-56.6%
49,800
-43.8%
0.00%
-66.7%
Q2 2021$175,000
+7.4%
88,6000.0%0.00%0.0%
Q1 2021$163,000
+239.6%
88,600
+469.7%
0.00%
+200.0%
Q3 2020$48,00015,5520.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 189,616$375,439,0001.17%
Ikarian Capital, LLC 1,365,059$2,703,0000.22%
Altium Capital Management LP 446,000$883,0000.20%
ASSET MANAGEMENT CORP /IL/ /ADV 91,500$181,0000.10%
Virtu Financial LLC 113,869$225,0000.02%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$20,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 155,069$307,0000.01%
McAdam, LLC 55,978$86,0000.01%
Moloney Securities Asset Management, LLC 27,340$54,0000.01%
Allen Capital Group, LLC 23,685$47,0000.01%
View complete list of HEPION PHARMACEUTICALS INC shareholders